Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

MeiraGTx will receive an upfront payment of $75 million and will be eligible to receive over $400 million in total milestone ...

Insilico will utilize its validated Pharma.AI platform and deep drug discovery expertise to generate, design, and optimize candidate compounds against targets defined under the agreement. Insilico is ...

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced a broad strategic collaboration in the area of ophthalmology with Eli Lilly and ...

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease INDIANAPOLIS, Nov. 10, 2025 /PRNewswire/ -- For Tan ...

Healthcare investors think OpenAI could build a personal health assistant complete with medical records, a project that's ...

Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCstm) to profoundly improve people's lives ...

The stock of Eli Lilly (LLY) has been upgraded by independent investment bank Leerink Partners as its weight-loss medications ...

Juntwillis Allen Sanders, age 33, transitioned peacefully, leaving behind a legacy of kindness and service. He was a ...

Samsung is showing off a couple of new storage products that it plans to showcase at CES in January 2026, one of which is a ...